About this episode

This episode features discussions on the management of relapsed/refractory multiple myeloma with insights from Dr Hans Lee and Dr Noopur Raje.

Featuring perspectives from Dr Hans Lee and Dr Noopur Raje, including the following topics: Introduction (0:00) Integrating Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies into the Management of Relapsed/Refractory Multiple Myeloma (R/R MM) — Dr Raje (4:30) Antibody-Drug Conjugates and Other Emerging Therapies for R/R MM — Dr Lee (28:33) CME information and select publications

People in this episode

Host: Dr Neil Love

Guests: Dr Hans Lee, Dr Noopur Raje

Topics covered

• Multiple Myeloma
• Chimeric Antigen Receptor T-Cell Therapy
• Bispecific Antibodies
• Relapsed/Refractory Multiple Myeloma
• Antibody-Drug Conjugates
• Emerging Therapies

Keywords

• Multiple Myeloma
• Chimeric Antigen Receptor T-Cell Therapy
• Bispecific Antibodies
• Antibody-Drug Conjugates
• Emerging Therapies
• CME information
• Oncology

More episodes of Hematologic Oncology Update

• For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress · July 16, 2026 · 1h 58m
• Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 9, 2026 · 1h 57m
• Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit · June 28, 2026 · 52 min
• Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit · June 24, 2026 · 51 min
• Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit · June 16, 2026 · 55 min
• Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit · June 15, 2026 · 1h 60m

Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.